Covey D C, Wright D G
Department of Orthopaedic Surgery, Naval Hospital, Bremerton, WA 98312-1898.
Mil Med. 1992 Mar;157(3):107-9.
Treatment of osseous defects by induced bone regeneration has yielded promising results in laboratory animals and in preliminary human trials. Two inducing agents, demineralized bone powder and bone morphogenetic protein, are being used clinically to treat some bony defects without the need for an autogenous bone-harvesting procedure. Such off-the-shelf bone-inducing agents may someday become a significant addition to the armamentarium of the military orthopedic surgeon for dealing with the numerous skeletal injuries which occur in today's service environment.
通过诱导骨再生治疗骨缺损在实验动物和初步人体试验中已取得了令人鼓舞的结果。两种诱导剂,即脱矿骨粉和骨形态发生蛋白,正在临床上用于治疗一些骨缺损,而无需进行自体骨采集手术。这种现成的骨诱导剂有朝一日可能会成为军事整形外科医生治疗当今服役环境中发生的众多骨骼损伤的重要工具。